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Abstract
Background: There is concern that the use of antimicrobials in livestock production has a role in the emergence
and dissemination of antimicrobial resistance in animals and humans. Consequently, there are increasing efforts to
reduce antimicrobial use (AMU) in agriculture. As the largest consumer of veterinary antimicrobials in several
countries, the pig sector is a particular focus of these efforts. Data on AMU in pig production in Ireland are lacking.
This study aimed to quantify AMU on Irish pig farms, to identify the major patterns of use employed and to
compare the results obtained to those from other published reports and studies.
Results: Antimicrobial use data for 2016 was collected from 67 Irish pig farms which represented c. 35% of national
production. The combined sample population consumed 14.5 t of antimicrobial by weight of active ingredient
suggesting that the pig sector accounted for approximately 40% of veterinary AMU in Ireland in 2016. At farm level,
median AMU measured in milligram per population correction unit (mg/PCU) was 93.9 (range: 1.0–1196.0). When
measured in terms of treatment incidence (TI200), median AMU was 15.4 (range: 0.2–169.2). Oral treatments
accounted for 97.5% of all AMU by weight of active ingredient and were primarily administered via medicated feed
to pigs in the post weaning stages of production. AMU in Irish pig production in 2016 was higher than results
obtained from the national reports of Sweden, Denmark, the Netherlands and France but lower than the United
Kingdom.
Conclusions: Pig production in Ireland is an important consumer of veterinary antimicrobials. The quantities and
patterns of AMU on Irish pig farms are comparable to pig production in other European countries but higher than
some countries with more advanced AMU reduction strategies. This AMU is characterised by a high proportion of
prophylactic use and is primarily administered to pigs post weaning via medicated feed. Further studies to better
understand the reasons for AMU on Irish pig farms and strategies to improve health among weaner pigs will be of
benefit in the effort to reduce AMU.
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Background
In the global effort to combat antimicrobial resistance a
‘One Health’ approach, encompassing human and animal
health as well as the environment, has been proposed [1,
2]. In common with other countries, Ireland has imple-
mented its own One Health action plan, iNAP (Ireland’s
National Action Plan against Antimicrobial Resistance)
[3]. Efforts to monitor and ultimately reduce antimicrobial
use (AMU) in livestock production are important compo-
nents of such plans [4]. These efforts are necessary as the
use of antimicrobials in livestock production has been
linked to the emergence and dissemination of antimicro-
bial resistant bacteria in animals and humans [5–7].
Pig production is the highest consumer of veterinary an-
timicrobials in many countries [8–10]. Until recently, only
a limited number of countries, such as Denmark [8] and
the Netherlands [9], monitored AMU stratified by species.
Currently, however, many countries have followed the ex-
ample of Denmark and the Netherlands and have devel-
oped, or are developing, their own AMU databases [11].
Data from some of these schemes were published recently,
for example, from Germany [12] and Belgium [10]. Else-
where, data on AMU in pig production derives from a
limited number of cross-sectional studies in countries
such as Canada [13, 14], Austria [15], France [16, 17],
Spain [18, 19] and Belgium [20] as well as two pan Euro-
pean studies [21, 22]. Several of these studies show that
the majority of antimicrobials are administered orally, as
group treatments, are frequently applied for prophylactic
(to prevent disease) or metaphylactic purposes (to treat a
group containing some diseased animals) and primarily
administered to pigs post weaning.
The pig population in Ireland comprises approxi-
mately 140–150,000 breeding animals and 1.5–1.6
million fattening pigs and is the third largest livestock
sector after dairy and beef [23, 24]. To date, data on
the use of antimicrobials in Irish pig production are
lacking but is reputed to be high [25].
The objectives of this study were 1) to quantify anti-
microbial use on Irish pig farms, 2) to determine the
major patterns of use employed, and 3) to compare the




A cross-sectional study was conducted on a convenience
sample of 67 Irish pig farms to investigate antimicrobial
usage. The participating farms were clients of the Tea-
gasc (The Agriculture and Food Development Authority)
farm advisory service1 which is available to all Irish pig
farms. In 2017, the Teagasc farm advisory service
included 107 pig farms, representing over 77,000 sows
(c. 50% of national herd); all farms were invited to par-
ticipate in the study and 67 agreed to co-operate. All
farms operated a farrow-to-finish system. Farrow-to-
finish enterprises account for virtually all of pig produc-
tion in Ireland [26].
Data collection
Farms were visited between September 2017 and Octo-
ber 2018 to collect detailed antimicrobial use data for
the 2016 calendar year. The farmers were asked to pro-
vide prescription and or invoice data in order to deter-
mine the amounts of antimicrobials used. Farmers were
asked to indicate which stages of production each anti-
microbial preparation was used in and whether any
prophylactic or metaphylactic use occurred during the
year. Population, feed consumption, performance and
production data were obtained from the Teagasc e-
Profit Monitor (ePM) database to which farmers submit
their data quarterly. Farmers not using the ePM (n = 8)
were asked to provide the relevant data directly.
Quantification of antimicrobial use
The amounts of active ingredient in each antimicrobial
product were determined according to the protocols
outlined by the European Medicines Agency (EMA) for
its European Surveillance of Veterinary Antimicrobial
Consumption (ESVAC) project [27]. Conversion factors
for prodrugs (such as procaine benzylpenicillin) and
international units (I.U.) were also obtained from the
ESVAC protocol.
Medicated feed
Antimicrobial oral premixes are remedies specifically
intended for use in medicated feed [28] and thus are dis-
tinct from oral remedies intended for use in water or
those added to feed as a ‘top dressing.’ While medicated
feeds may include other types of medication (for ex-
ample, anthelmintics, anti-inflammatories or zinc oxide),
in this article, the term ‘medicated feed’ will refer to
feeds or diets including antimicrobial oral premixes. Spe-
cific diets are fed during each stage of pig production
and any of these diets may be medicated with antimicro-
bials. The stages of production on Irish pig farms are
summarised as follows: piglets are generally weaned at
around 28 days, the weaned piglets remain in the weaner
stage, which, on Irish farms is typically split into first
and second stages, for up to 9 weeks and, thereafter, the
pigs stay in the finisher stage until slaughter, at around
24 weeks of age. A creep or pre-starter diet is provided
to piglets in the farrowing house; after weaning, the pigs
are typically fed a starter diet for 7–14 days, followed by
a link diet for another 7–14 days and then a weaner diet
for the remainder of the weaner stage; finally, finisher1https://www.teagasc.ie/animals/pigs/
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pigs are fed a finisher diet. Sows are fed specific diets de-
pending on whether they are in gestation or lactation.
The amount of medicated diet used in each category for
each antimicrobial included was determined by 1) con-
sulting data submitted to the ePM, 2) invoice records, or
3) data provided directly by the farmer. To calculate the
amounts of antimicrobial administered in medicated
feed the following formula was used:
weight of medicated feed kgð Þ
 inclusion rate of active ingredient mg=kgð Þ
The inclusion rate was expressed in terms of mg of
antimicrobial per kg of medicated feed (e.g. chlortetra-
cycline 300 mg/kg). This calculation was performed for
every combination of diet and antimicrobial inclusion
rate.
Other oral remedies and parenteral preparations
Complete prescription records for other oral remedies
and parenteral preparations were not available for five
farms. In these cases, missing values for each antimicro-
bial product used on the farm were imputed based on ei-
ther the estimate of use provided by the farmer or the
median value of use on the other farms using the same
product. To calculate the amounts of antimicrobials ad-
ministered by other routes of administration the follow-
ing formula was used:
number of packs pack size g or mlð Þ
 strength mg=ml or mg=kgð Þ
This calculation was performed for each preparation
of each active ingredient.
Treatable kilograms
In order to adjust for differences in potency between the
various active ingredients, the amounts used of each
antimicrobial were adjusted to ‘treatable kilograms’ (TK)
based on the Defined Daily Dose for the given active in-
gredient (DDDvet) as defined by ESVAC [29]. ‘Treatable
kilograms’ represents the number of kilograms of pig
which can be treated with the given amount of anti-
microbial if the Defined Daily Dose is used. For example,
20 mg of marbofloxacin (DDDvet = 2mg/kg) can treat
10 kg of pig. This calculation is based on the definition
outlined by the Netherlands Veterinary Medicines Insti-
tute [9]:
treatable kilograms ðTKDDDvetÞ
¼ amount of antimicrobial used ðmgÞ
DDDvetðmg=kgÞ
Two antimicrobials, tulathromycin and tildipirosin, do
not have an assigned DDDvet; the defined daily animal
doses (DDDA) and long acting factors defined by
Postma et al. were used [30].
Indicators of antimicrobial use at farm level
The milligram per population correction unit (mg/PCU)
was developed by the EMA and is the indicator of anti-
microbial consumption used in the ESVAC reports on
sales of veterinary antimicrobials in the European Union
(EU) and European Economic Area (EEA) [31]. The mg/
PCU uses the weight of active ingredient as the numer-
ator while the population correction unit (PCU) is used
as the denominator. The PCU assigns a standardised
weight to each species and to sub-categories where ap-
plicable [31]. The calculation of mg/PCU for pigs is fur-
ther described in Additional file 1.
Treatment incidence (TI) represents the percentage of
pigs in a stage of production treated with a dose of anti-
microbial each day or, the percentage time of the period
at risk for which a pig was treated. The TI indicator, as
defined for pigs by Timmerman et al. [32] and adapted
by Sarrazin et al. [22], was calculated as follows:
TIDDDvet ¼ amount of antimicrobial used ðmgÞDDDvetðmg=kgÞ  kg of animal at riskðkgÞ  number of days at risk
 100 animals at risk
The numbers of animals at risk and numbers of days
at risk for each category were derived from ePM or farm
data. For a detailed description of the TI calculation see
Additional file 1. The TIDDDvet was calculated for each
antimicrobial per age category (piglet, weaner, finisher
and sow). Finally, the TI for piglets, weaners and fin-
ishers were combined and recalculated as a standardised
TI200 using the formula defined by Sjölund et al. [21]:
TI200 ¼ TIpiglet  suckling period þ TIweaner  weaner period þ TI finisher  finishing period
total rearing period
 200ðstandard li fespanÞ
total rearing period
Comparison to AMU in selected European countries
Data concerning the weight of antimicrobials used or
sold in pig production during 2016 were extracted from
the national reports of the following countries: Sweden
[33], Netherlands [34], Denmark [35], and France [36].
The value obtained was divided by the corresponding
PCU for pigs extracted from the ESVAC report for 2016
[37] to calculate consumption in mg/PCU. Antimicrobial
use in pigs in the United Kingdom (UK) for 2016 was
based on data collected by the e-medicine book for pigs
(eMB pig) and was reported in mg/PCU [38].
To allow a further comparison with the national AMU
consumption reports of Denmark and the Netherlands
for 2016, the total AMU of the combined population of
the sample farms was recalculated using their respective
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indicators. The DAPD, defined as the ‘proportion of
population in treatment per day’, is the indicator used to
report AMU at national level in Demark [8] and the
DDDANAT (Defined Daily Dose Animal) is used in the
national reports of the Netherlands [9]. For further de-
tails, see Additional file 1.
Data processing
All data were entered into a Microsoft® Excel 365
spreadsheet. Calculations and descriptive statistical ana-
lysis were carried out using Microsoft® Excel and R ver-
sion 3.4.2 [39]. Data visualisation was carried out using
the R packages ggplot2 [40] and VennDiagram [41].
Results
Farm characteristics
The 67 farms included in the study had a median herd
size of 528 sows (range 110–3000) and median produc-
tion of 12,429 pigs for slaughter (range 2600–58,300)
during 2016. The combined population of the 67 farms
was approximately 48,000 sows and thus represented
around 35% of the national herd in 2016 [42].
Overview of antimicrobial consumption
The total estimate of antimicrobial use on the 67 study
farms during 2016 by weight of active ingredient was
14.5 t, comprising a total of 19 different antimicrobial
compounds. Table 1 summarises the patterns of anti-
microbial use and shows the breakdown of use by route
of administration for each antimicrobial class. The ma-
jority of antimicrobials, representing 97.5% of the weight
of active ingredient and 93.9% of treatable kilograms
(TKDDDvet), were administered orally and mainly in med-
icated feed. One farm did not use any oral treatments
while all farms used injectable treatments. Tetracyclines,
potentiated sulphonamides, macrolides and penicillins
accounted for almost all antimicrobials consumed
(98.2% of the weight of active ingredient; 94.3% of
TKDDDvet). The use of tetracyclines in medicated feed
had the highest impact on consumption, was observed
on 64.1% of farms and accounted for more than half all
AMU by weight of active ingredient (32.4% of TKDDDvet).
Some patterns of use, while not impacting greatly on
overall consumption, were observed on most farms. For
example, all farms used injectable penicillins (amoxycil-
lin or benzylpenicillin) and 83.6% of farms used inject-
able fluoroquinolones (enrofloxacin and marbofloxacin).
Antimicrobial use was highest in weaner pigs, which
accounted for 69.7% of AMU by weight of active ingre-
dient and 63.2% of TKDDDvet. Finisher pigs accounted
for 25.4% of AMU by weight of active ingredient and
30.6% of AMU by TKDDDvet; sows accounted for 4.1% of
AMU by weight of active ingredient and 3.5% of AMU
by TKDDDvet and piglets accounted for 0.9% of AMU by
weight of active ingredient and 2.7% of AMU by
TKDDDvet (see also Supplementary Table 1, Add-
itional file 2). The indicators of AMU at farm level in
mg/PCU and treatment incidence (TI200) are sum-
marised in Table 2.
Antimicrobial use in medicated feed
Figure 1 summarises AMU in medicated feed for each
diet category. Sixty-one farms (91% of the sample) used
medicated feeds during 2016 and this accounted for
89.1% of all AMU by weight of active ingredient (83.1%
of TKDDDvet). The percentage of farms medicating each
diet category and the patterns of use employed are illus-
trated in Fig. 2. The majority of medicated feed was pro-
vided to pigs in the post weaning stages of production
and accounted for 66.3% of all AMU by weight of active
ingredient (58.6% of TKDDDvet). Most farms (88.1% of
sample) medicated at least the starter and/or link diets,
meaning that most pigs in the study were treated with
antimicrobials during the first 7–21 days post weaning.
Thirty-five farms (52.2% of sample) also provided medi-
cated creep diets to piglets in the farrowing house. Anti-
microbial use in the starter and link diets accounted for
14.8% of weight of active ingredient and 19.0% of
TKDDDvet. Regarding the active ingredients used, there
was more variation in these diets compared to the other
diet categories; tetracyclines, potentiated sulphonamides,
macrolides, penicillins and aminoglycosides were all
commonly used. Medicated weaner diets, mainly with
tetracyclines or potentiated sulphonamides, were used
on 38 farms (57.7% of sample). They generally followed
medication in the starter and/or link diets (see Fig. 2)
and accounted for 50.5% of total AMU by weight of ac-
tive ingredient (39.6% of TKDDDvet). Antimicrobial use in
medicated feed in the weaner stages was generally for
prophylactic purposes; farms applied the same protocol
to every batch produced during the year. In the finisher
stage, medicated feed was used on 16 farms (23.9% of
sample) and contributed to 20% of overall use by weight
of active ingredient (22.3% of TKDDDvet). Tetracyclines
and macrolides were the most commonly used classes in
finisher diets, however, heavy use of sulfadiazine and tri-
methoprim on one farm meant it was the antimicrobial
with the highest consumption in this category. Routine
prophylaxis was less common and practised by six farms.
In addition, 25.4% of farms provided medicated feed to
sows, typically once or twice per year for a period of 7–
10 days. The antimicrobials used in medicated feed var-
ied within the farm, between diets and over time. Half of
all farms used 3 or more antimicrobials (see Supplemen-
tary Figure 1, Additional file 2). This reflects the fact
that some farms used combinations of antimicrobials, ei-
ther combination products or custom formulations; that
some farms changed treatment regime during the year
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and, that the antimicrobials included often varied from
one diet to the next. Twenty-three of the 46 farms rou-
tinely medicating both the starter and link diets used the
same treatment regime in both diets; of those farms that
also medicated the weaner diet, all but one farm used a
different antimicrobial.
Antimicrobial use in other routes of administration
The use of antimicrobials in injectables and oral remed-
ies (other than premix) in weight of active ingredient
and treatable kilograms is illustrated in Fig. 3. Forty-
three farms (64.2% of sample) administered antimicro-
bials in water. This route of administration accounted
for 7.2% of consumption by weight of active ingredient
(10% of TKDDDvet). Macrolides and penicillins were the
antimicrobial classes with the highest consumption (see
Table 1). The most frequent practice was the adminis-
tration of the aminoglycoside antimicrobial, apramycin,
which was typically provided in drinkers in the farrowing
house or post weaning to treat gastroenteritis and was
used on 41.8% of farms. Top dressing, mainly with
chlortetracycline, was typically administered to older
weaners, finishers or sows, accounted for 1.11% of AMU
by weight (0.7% of TKDDDvet) and was used on 16 farms
(23.9% of sample). Oral dosing was recorded on 21 farms
(31.3% of sample) and accounted 0.03% of AMU by
weight of active ingredient and 0.02% of TKDDDvet.
Injectable antimicrobial remedies represented the third
most important route of administration. Penicillins were
the most used injectable antimicrobial class; all farms
used amoxicillin and/or benzylpenicillin (+/− strepto-
mycin). When measured by weight of active ingredient
injectables accounted for 2.5% of all AMU and 6.2% of
TKDDDvet.
Highest priority critically important antimicrobials
The highest priority critically important antimicrobials
(HP CIA), as defined by the World Health Organisation
(WHO) [43], used on Irish pig farms included: macro-
lides; fluoroquinolones (enrofloxacin, marbofloxacin);
third generation cephalosporins (ceftiofur); and poly-
myxins (colistin). The oral macrolides, mainly tylosin
but also tilmicosin, represented 9.3% of all AMU by
weight of active ingredient and 15.2% of TKDDDvet. The
long acting injectable macrolides, tulathromycin and til-
dipirosin, were not widely used but nevertheless
accounted for 12.5% of injectable TKDDDvet. The EMA
classifies the fluoroquinolones, polymyxins and 3rd and
4th generation cephalosporins as category B antimicro-
bials (‘restrict’) and macrolides as category C (‘caution’)
and thus differs from the WHO classification by ranking
Fig. 1 Consumption of the various classes of antimicrobials in medicated feed on 67 Irish pig farms, 2016. The data is stratified by weight of
active ingredient, the number of treatable kilograms and the percentage of farms with use for each category of diet. Six farms did not use
medicated feed during 2016 and some farms used more than one antimicrobial in a given diet during the year
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macrolides lower than the other HP CIAs [44]. In terms
of overall use, category B antimicrobials represented
0.33% of the weight of active ingredient used; however,
when measured in TKDDDvet they accounted for 2% of
consumption (see Table 1). Seven farms (10.4% of sam-
ple) did not use any category B antimicrobials during
2016 while most farms (85.1% of sample) used fluoroqui-
nolones. The use of category B antimicrobials at farm
level is summarised in Table 2. These were mainly ad-
ministered to suckling piglets and weaned piglets where
the highest treatment incidences were observed. In con-
trast, most farms did not administer category B antimi-
crobials to finisher pigs or to sows; median TIs in both
of these age groups was zero.
Prophylactic use
In addition to prophylactic AMU in medicated feed,
farmers practised other methods of prophylactic treat-
ment. Piglets were injected at birth, processing (iron in-
jection, clipping teeth and tail docking; typically
performed during the first week of life) or at weaning on
35 farms (52% of sample). Amoxicillin was the most
commonly used drug (n = 16; 23.8% of sample) but five
other classes of antimicrobial were utilised, notably: cef-
tiofur on six farms and long acting macrolides on five
farms. In the weaner stage, other oral remedies, mainly
amoxicillin (n = 4), chlortetracycline (n = 2) and tylosin
(n = 1) were used as prophylaxis on seven farms (10.4%
of sample). In finisher pigs, similar practices were ob-
served on three farms: amoxicillin (n = 1); tylosin (n = 2).
Sows received prophylactic treatments on 11 farms
(16.4% of sample), most frequently in the form of an
antimicrobial injection at either farrowing or weaning
(eight of 11 farms). Oral chlortetracycline was adminis-
tered to sows on four of the 11 farms. These practices
accounted for a significant proportion of their respective
routes of administration, for example prophylactic use of
water soluble antimicrobials accounted for 78.8% of use
in this route of administration by weight of active ingre-
dient (for further details see Supplementary Table 2,
Additional file 2).
Comparison of AMU in Irish pig production to other
countries
Figure 4 illustrates the comparison between AMU on
the Irish sample farms and AMU as derived from the re-
ports of Sweden, Denmark, the Netherlands, France and
the UK in 2016. Antimicrobial use for the combined
sample population of 67 Irish pig farms was 161.9 mg/
PCU and was the second highest of the 6 countries
Fig. 2 Venn diagram showing patterns of antimicrobial use in medicated feed for growing pigs on 67 farms, 2016. Each set contains the farms
medicating the given diet category during 2016: starter, link, weaner and finisher. The percentage and number of farms medicating each diet
category are shown in parentheses after the corresponding set title. The values within the sets show the percentage of farms (number in
parentheses) with each pattern of use. For example, 6% of the study farms (n = 4) medicated the link diet only; 22.4% of the study farms (n = 15)
medicated the starter, link, weaner and finisher diets. The values outside of the 4 sets indicate farms that did not use medicated diets
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behind the UK. Figure 4 also summarises the compari-
son of AMU between the Irish sample population and
the Danish and Dutch pig production sectors using their
respective national indicators. When measured in mg/
PCU, AMU on the Irish pig farms was approximately 3.7
times higher than consumption in both Denmark and
the Netherlands. However, when measured in their re-
spective national indicators, DAPD and DDDANAT, the
relative differences were reduced. For the Irish study
sample population, the DAPD was 3.2 times higher than
that for Danish pig production while the DDDANAT was
2.5 times higher than Dutch pig production.
Discussion
This study presents the first detailed data on antimicro-
bial use in the Irish pig industry. The study sample rep-
resented approximately 35% of the national herd and
while it cannot be assumed to be representative of the
whole of Irish pig production, the results obtained pro-
vide useful insights into antimicrobial use in the indus-
try. Whether measured by weight of active ingredient or
in defined daily doses (TKDDDvet) almost all antimicro-
bials were administered orally and primarily to pigs in
the weaner stage of production. This is in agreement
with several European studies [17–22, 45] and national
reports [8, 9]. Approximately 103 t of veterinary antimi-
crobials were sold in Ireland during 2016, based on sales
data submitted by Marketing Authorisation Holders to
the Health Products Regulatory Authority [46]. Extrapo-
lation of the results from this study suggests that pig
production accounts for approximately 40% of veterinary
AMU in Ireland. While this estimate must be inter-
preted with caution, the data from this study suggest
that pigs consume all the oral premix antimicrobials
(which accounted for one third of all sales in 2016) but
are not significant consumers of the other oral remedies
or injectable antimicrobials (which accounted for 33 and
27% of all sales respectively) [46].
Irish pig farms were also similar to European farms in
that so called ‘older classes’ of antimicrobials such as tet-
racyclines, potentiated sulphonamides, penicillins, and
macrolides were the most used. Macrolides, the third
most used class overall, are classified as HP CIA by the
WHO but category C (‘caution’) by the EMA. The differ-
ence in ranking between the EMA and WHO results
from the EMA’s assessment of the importance of this
class to veterinary medicine and the fact that for some
conditions macrolides represent the only suitable treat-
ment [44]. Colistin, classified as a HP CIA by the WHO
[42] and category B (‘restrict’) by the EMA [44] and
Fig. 3 Consumption of oral remedies other than premix and parenteral antimicrobials expressed in weight of active substance and treatable
kilograms (TKDDDvet) from 67 Irish pig farms, 2016. Other oral remedies include oral remedies for inclusion in water, oral powders for inclusion in
feed as a ‘top dressing’ and, oral doses
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widely used in European pig production [21, 22] was not
widely used on Irish farms. Use of cephalosporins and
fluoroquinolones (both HP CIA and category B) was also
relatively low; however, in countries such as the
Netherlands [9] and Denmark [8] where there are re-
strictions, their use in pig production is negligible or
zero. Furthermore, fluoroquinolones along with cephalo-
sporins, constituted 21.8% of injectable AMU when mea-
sured in TKDDDvet. Since piglet was the age group with
the highest exposure to injectable antimicrobials, this
implies large proportions of the pig population may re-
ceive treatment with these drugs at some point in their
life cycle. The widespread use of fluoroquinolones, in
particular, is concerning as there is evidence of increas-
ing fluoroquinolone resistance amongst Escherichia coli
isolates of porcine origin in Ireland. Data from the Euro-
pean Food Safety Authority (EFSA) monitoring program
showed that resistance to ciprofloxacin increased from
2% in 2015 to 7% in 2017 [47, 48].
In this study, 95.6% of all AMU by weight of active in-
gredient (89.5% of TKDDDvet) could be classed as
prophylactic. Sarrazin et al. reported increased treatment
frequency at 1, 4 and 9 weeks of age which coincided
with birth and associated procedures such as teeth clip-
ping and castration, weaning, and transfer to the finisher
stage, respectively [22]. Farmers administer prophylactic
treatments at these time points to prevent losses associ-
ated with expected disease associated with the stresses
of handling, movement and dietary changes [49]. Over
half of the study farms administered prophylactic anti-
microbial treatments during the first week of life and
88.1% of farms provided antimicrobials in medicated
feed at or just after weaning. On 56.7% of farms, medi-
cated feed was provided in the weaner diet. This is fed at
the end of the first weaner stage and throughout the sec-
ond weaner stage and thus covers another transfer be-
tween production stages. Therefore, in contrast to
Sarrazin et al., where treatments appeared to be adminis-
tered at strategic times [22], many farms in Ireland ad-
minister antimicrobials at, between and after these
times. An important reason for this difference is related
to the feeding infrastructure. On most farms, a single
feed bin supplies one or more houses containing pigs of
different ages. If medicated feed is to be provided to the
younger pigs just after transfer, the older pigs must be
medicated as well. With regard to the weaner and fin-
isher diets, this has important implications for the over-
all amounts of antimicrobial consumed since the older
and heavier the pig, the more it eats. Similar structural
issues were reported on Belgian farms using
Fig. 4 Comparison of antimicrobial use between the 67 Irish pig farms and 5 European countries in 2016. The large panel shows the comparison
of antimicrobial use (AMU) between the Irish sample population and five European countries expressed in mg/PCU [31]. The smaller panels show
the comparison of AMU between the Irish sample population and Denmark expressed in DAPD (proportion of animal population in treatment
per day) [8] and between the Irish sample population and the Netherlands expressed in DDDANAT (defined daily dose animal) [9]
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medicated feed [50] and demonstrate the importance
of improving antimicrobial delivery systems in efforts
to reduce AMU [51].
Quantitative comparisons between studies and na-
tional reports are hampered by the use of different indi-
cators of AMU. Use of the mg/PCU indicator, developed
by ESVAC [31], allowed a comparison of AMU between
the sample population in this study and the 2016 na-
tional reports of Sweden, Netherlands, Denmark, France
and the UK to be made. Antimicrobial consumption for
the combined population of Irish farms was the second
highest of the six countries compared. Irish AMU was
3.2 and 2.5 times higher than Denmark and the
Netherlands, respectively, when measured in their na-
tional indicators. The TI200 indicator allowed a com-
parison of use at farm level between the study farms and
the study by Sarrazin and colleagues [22]. Using pur-
chase data for 1 year, the median TI200 for 180 farrow-
to-finish farms from nine countries in 2015 was 7.1. For
the Irish farms in 2016, the median TI200 was 15.3. This
comparison should be made with caution. The weaner
stage on the Irish study farms was generally longer (me-
dian = 9 weeks, data not shown) than the European
farms (median = 6.5 weeks) [22]. Since most of the AMU
is administered in the weaner diet fed to older weaner
pigs, the weight at treatment used to calculate the TIwea-
ner is underestimated. This in turn means that the TI200
is overestimated. Also, the farrow-to-finish system ac-
counts for almost all pig production in Ireland [26], and
in this regard, the study is representative of the whole
industry. In other countries, where specialised weaner
and finisher farms are more prominent [26] measuring
AMU on farrow-to-finish farms may not be representa-
tive. Some studies have found that AMU is higher in fin-
isher pigs on specialised finisher farms than on farrow-
finish farms and suggest the stress of transport and mix-
ing pigs from different sources as a possible explanation
[12, 19, 52]. Nevertheless, these results show that AMU
in Irish pig production compared unfavourably to some
of its European peers in 2016. It should be noted, how-
ever, that comparable data from many other countries is
not yet available and that those countries with AMU
data are, in general, further into their respective ‘action
plans’ against antimicrobial resistance than Ireland.
These findings highlight the need to reduce AMU in
Irish pig production. New EU regulations governing
antimicrobial use and medicated feed, which come into
effect in 2022, will prevent prophylactic AMU and re-
strict metaphylactic group treatments as well as the use
of CIAs [28, 53]. This will require a significant shift in
behavioural and management practices related to AMU
on Irish pig farms, particularly with regard to routine
prophylactic use in feed medication. A pilot study car-
ried out on an Irish farm suggests this can be achieved
without impacting welfare or performance [54, 55] and
as an example, if AMU in medicated feed in the weaner,
finisher and sow diets were removed from the current
study, total AMU for the sample population would re-
duce to 43.1 mg/PCU which is just below the levels for
Denmark and the Netherlands. It should be noted that
several farms in the study were already at or below this
level of AMU (see Fig. 2); six farms (9% of sample) did
not use any medicated feed and seven (10.4% of sample)
did not use any category B antimicrobials. The risk fac-
tors for AMU on Irish pig farms have not been studied.
However, recent work has identified respiratory disease as
a significant problem on Irish pig farms [56] and this may
explain the high use of antimicrobials in the weaner diets
fed to 2nd stage weaner pigs. Also, internal biosecurity on
Irish pig farms is lower than in other European countries
[57]. Improved biosecurity was shown to aid in reducing
AMU on Belgian pig farms [58] and a recent initiative
launched by Animal Health Ireland has made biosecurity
audits available to all Irish pig farms.2 Other initiatives
such as measuring AMU, increased education and the
promotion of responsible use guidelines, which are all part
of iNAP [3], have had success in reducing AMU in pig
production in other countries [59]. The recent launch of
the ‘national AMU database for pigs’ by the Department
of Agriculture Food and the Marine has fulfilled a key pri-
ority of iNAP and will allow for the monitoring of AMU
in Irish pig production and for the assessment of the im-
pact of AMU reduction strategies [60].
The main limitation of this study is that the data was
collected from a convenience sample of farms and thus
may not be representative of the entire population. The
farms used in this study had originally volunteered to
take part in a survey investigating biosecurity and man-
agement practices and could represent farms with better
practices than the rest of the population which could
have introduced a selection bias. Nevertheless, the study
population represented around 35% of the national herd
and therefore a significant proportion of the industry.
Collecting AMU data in the field presents challenges.
Records are not always kept [20, 22] and antimicrobial
preparations are often used in different age groups with-
out records of which pigs they were allocated to [22]
and, therefore, assumptions and imputations had to be
made in some instances. There were similar challenges
in this study. Where records were incomplete, estima-
tions of AMU were given by the farmer and could be
subject to recall bias and intervention bias (where the
farmer deliberately under reports AMU). Since the ma-
jority of AMU was via medicated feed and is an import-
ant part of farm management, the risk of recall bias is
considered to be low for this route of administration.
2http://animalhealthireland.ie/?page_id=18234
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Overall, approximately 96% (94% of TKDDDvet) of the an-
timicrobials used could be accurately assigned to the
correct age group.
Conclusions
Antimicrobial use on Irish pig farms is characterised by
a high proportion of prophylactic use, primarily deliv-
ered using medicated feed and mainly administered to
pigs in the post weaning production stages. These pat-
terns of use are similar to those reported in other Euro-
pean studies although the amounts used are higher than
some countries such as Sweden, Denmark and the
Netherlands. This study confirms that pig production is
an important consumer of veterinary antimicrobials, ac-
counting approximately for 40% of AMU in Ireland in
2016; and reinforces the need to reduce AMU. The iden-
tification of the pattern of use with the highest impact
on consumption, the provision of medicated feed to
weaner pigs, suggest that efforts to understand the rea-
sons for this and promote better health among weaner
pigs will be of benefit.
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